The Archive · 7 posts
Revolutionising healthcare with AI! 🏥 Medpal AI PLC (MPAL) leads the charge in medical innovation on the LSE. 🤖
MedPal AI's annualised revenue run rate reached £8.6 million in July, supported by NHS dispensing, private prescriptions and SaaS.
August 4, 2026
Showing 6 of 7 posts
MedPal AI's eMARx acquisition adds profitable software, care home customers and a potential sales channel for its pharmacy services.
JoshuaJuly 20, 2026
MedPal AI's first revenue of £1.6M in interim results signals traction, but cash burn and dilution are key risks for investors.
JoshuaMay 29, 2026
MedPal AI acquires Remedi pharmacy assets for £310k, adding a second NHS hub with a clear path to 80k items/month breakeven.
JoshuaApril 29, 2026
Medpal AI completes low-cost pharmacy acquisition, triples robotic hub capacity to over 100,000 scripts monthly, advancing its vertically integrated NHS model.
JoshuaFebruary 16, 2026
MedPal AI's Eli Lilly pact brings direct Mounjaro access, targeting the private UK weight loss market where it holds 79% share.
JoshuaJanuary 28, 2026
MedPal AI reports 16% pharmacy growth with FDA's oral GLP-1 approval set to expand the weight-loss market. Insights inside.
JoshuaJanuary 5, 2026
April 29, 2026